Skip to main content
. 2014 Jul 28;26(3):735–745. doi: 10.1681/ASN.2014030228

Table 1.

Clinical characteristics of patients in groups 1 and 2 before transplantation

Condition Group 1 (n=89; IgA aB2GPI-Positive) Group 2 (n=180; IgA aB2GPI-Negative) P Value
N or Mean SEM or Percent N or Mean SEM or Percent
Sex (women) 42 47.2% 82 45.6% 0.90
Weight (kg) 67.2 ±1.5 66.8 ±1.0 0.81
Height (cm) 163.5 ±1.0 165.4 ±0.7 0.16
Age (yr) 55.9 ±1.3 47.9 ±1.0 <0.001
Donor age (yr)a 53.1 ±2.0 43.5 ±1.4 <0.001
Time on dialysis (mo) 27.7 ±3.1 37.1 ±3.7 0.10
Peritoneal dialysis 14 15.7% 24 13.3% 0.73
Causes of CKD
 Chronic GN 18 20.2% 51 28.3% 0.20
 Interstitial kidney disease 20 22.5% 33 18.3% 0.52
 Nephroangiosclerosis 5 5.6% 21 11.7% 0.17
 Polycystic kidney disease 15 16.9% 29 16.1% 0.98
 Diabetes 11 12.4% 13 7.2% 0.25
 Unknown 11 12.4% 14 7.8% 0.32
 Other 9 10.1% 19 10.6% 0.92
Pretransplant
 Severe thrombosis before transplantb 10 11.2% 7 3.9% 0.04
 Stroke 3 3.4% 1 0.6% 0.12
 Peritoneal dialysis 14 15.7% 24 13.3% 0.73
 Dyslipidemia 23 25.8% 62 34.4% 0.20
 Diabetes mellitus 14 15.7% 17 9.4% 0.19
 Previous transplant 3 3.4% 34 18.9% 0.001
 Double renal transplant 9 10.1% 13 7.2% 0.56
 PRA>50% (at time of transplant) 3 3.4% 6 3.3% 0.73
 Historical PRA>50% 9 10.1% 28 15.6% 0.30
 Cold ischemia (h) 20.7 ±0.6 19.8 ±0.4 0.18
 Warm ischemia in recipient (min) 31.0 ±0.7 31.1 ±0.5 0.91
a

Donor age is a recipient age-dependent variable.

b

Excluding vascular access.